Outpatient blind percutaneous liver biopsy in infants and children: is it safe?

Background/aim: We aim to investigate the safety of outpatient blind percutaneous liver biopsy (BPLB) in infants and children with chronic liver disease (CLD).

Patients And Methods: BPLB was performed as an outpatient procedure using the aspiration Menghini technique in 80 infants and children, aged 2 months to 14 yrs, for diagnosis of their CLD. Patients were divided into three groups: Group 1 (<1 year), group 2 (1-6 yrs), and group 3 (6-14 yrs).

Diagnosis of spontaneous bacterial peritonitis in infants and children with chronic liver disease: A cohort study.

Background: Spontaneous bacterial peritonitis (SBP) is a serious complication in infants and children with chronic liver disease (CLD); however its diagnosis might be difficult. We aimed to study the feasibility of diagnosing SBP by routine ascitic fluid tapping in infants and children with CLD.

Methods: We enrolled thirty infants and children with biopsy-proven CLD and ascites.